Vor Biopharma Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 39.65 M | $44.01 M | 74.28% | 57.91% |
FMR LLC | 02/13/2025 | 6.42 M | $7.13 M | -9.21% | 9.38% |
5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 6.36 M | $7.06 M | 0.00% | 9.29% |
VANGUARD GROUP INC | 02/11/2025 | 1.94 M | $2.16 M | -0.59% | 2.84% |
JOHNSON & JOHNSON | 02/13/2025 | 1.07 M | $1.19 M | 0.00% | 1.57% |
LYNX1 CAPITAL MANAGEMENT LP | 02/14/2025 | 637,218 | $707,312 | 100.00% | 0.93% |
SARISSA CAPITAL MANAGEMENT LP | 02/14/2025 | 618,000 | $685,980 | 0.00% | 0.90% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 529,500 | $587,745 | -29.96% | 0.77% |
BLACKROCK, INC. | 02/07/2025 | 488,363 | $542,083 | 0.15% | 0.71% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 422,143 | $468,712 | 0.00% | 0.62% |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 329,378 | $365,610 | 0.00% | 0.48% |
MAI CAPITAL MANAGEMENT | 02/14/2025 | 283,199 | $314,351 | -40.49% | 0.41% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 261,837 | $290,639 | -13.82% | 0.38% |
CITADEL ADVISORS LLC | 02/14/2025 | 200,405 | $222,450 | 28,007.29% | 0.29% |
EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 165,805 | $184,044 | 0.00% | 0.24% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 163,064 | $181,001 | 18.91% | 0.24% |
MORGAN STANLEY | 02/14/2025 | 159,910 | $177,500 | 554.08% | 0.23% |
NORTHERN TRUST CORP | 02/14/2025 | 157,617 | $174,955 | 39.04% | 0.23% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 132,600 | $147,186 | -2.43% | 0.19% |
STATE STREET CORP | 02/14/2025 | 115,934 | $128,687 | 0.00% | 0.17% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 115,028 | $127,681 | 100.00% | 0.17% |
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 02/14/2025 | 91,910 | $102,020 | 100.00% | 0.13% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 86,685 | $95,000 | 6.62% | 0.13% |
XTX TOPCO LTD | 02/13/2025 | 71,788 | $79,685 | 100.00% | 0.10% |
BOLLARD GROUP LLC | 02/14/2025 | 55,555 | $62,000 | 0.00% | 0.08% |
VIRTU FINANCIAL LLC | 02/11/2025 | 54,470 | $60,000 | 100.00% | 0.08% |
LMR PARTNERS LLP | 02/14/2025 | 51,111 | $56,733 | 0.00% | 0.07% |
HSBC HOLDINGS PLC | 02/14/2025 | 44,728 | $48,754 | 0.00% | 0.07% |
MARSHALL WACE, LLP | 02/13/2025 | 37,190 | $41,281 | -68.11% | 0.05% |
GABELLI & CO INVESTMENT ADVISERS, INC. | 02/13/2025 | 30,000 | $33,300 | 100.00% | 0.04% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 28,090 | $31,180 | -4.88% | 0.04% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 27,500 | $30,525 | -45.33% | 0.04% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 26,698 | $29,635 | -5.42% | 0.04% |
MONEY CONCEPTS CAPITAL CORP | 01/27/2025 | 25,000 | $27,750 | 0.00% | 0.04% |
CITADEL ADVISORS LLC | 02/14/2025 | 20,900 | $23,199 | 124.73% | 0.03% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 16,102 | $17,873 | 100.00% | 0.02% |
BARCLAYS PLC | 02/13/2025 | 11,024 | $12,000 | 0.00% | 0.02% |
JPMORGAN CHASE & CO | 02/12/2025 | 10,667 | $11,840 | -11.39% | 0.02% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 10,069 | $11,177 | 100.00% | 0.01% |
WEDBUSH SECURITIES INC | 02/13/2025 | 10,000 | $11,000 | 100.00% | 0.01% |
SIMPLEX TRADING, LLC | 02/11/2025 | 4,569 | $5,000 | -9.58% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 3,601 | $3,997 | -16.22% | 0.01% |
FEDERATED HERMES, INC. | 02/13/2025 | 3,045 | $3,380 | -18.99% | 0.00% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 2,422 | $2,688 | 100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 2,393 | $2,656 | -59.24% | 0.00% |
CITADEL ADVISORS LLC | 02/14/2025 | 2,100 | $2,331 | 2,000.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 1,149 | $1,275 | 100.00% | 0.00% |
02/06/2025 | 481 | $534 | 100.00% | 0.00% | |
EAGLE BAY ADVISORS LLC | 01/13/2025 | 150 | $167 | 0.00% | 0.00% |
POINT72 (DIFC) LTD | 02/14/2025 | 26 | $29 | 0.00% | 0.00% |
Vor Biopharma Inc. institutional Ownership - FAQ's
During the previous two years, 68 institutional investors and hedge funds held shares of Vor Biopharma Inc.. The most heavily invested institutionals were:
NBC SECURITIES, INC.: 0
RA CAPITAL MANAGEMENT, L.P.: 39.65 M
FMR LLC: 6.42 M
5AM Venture Management, LLC: 6.36 M
VANGUARD GROUP INC: 1.94 M
JOHNSON & JOHNSON: 1.07 M
89.00% of Vor Biopharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 63.95 M shares in the last 24 months. This purchase volume represents approximately $44.89 M in transactions.